BioCentury | Dec 5, 2011
Company News

IsoRay sales and marketing update

...GliaSite radiation therapy system in the U.S. for use with Iotrex to treat brain cancer. IsoRay...
...for brain cancer from Dr. Reddy's Laboratories Ltd. (NYSE:RDY, Hyderabad, India) (see BioCentury, Sept. 19). IsoRay Inc....
BioCentury | Sep 19, 2011
Clinical News

GliaSite radiation therapy system regulatory update

...the GliaSite radiation therapy system for use with Iotrex to treat brain cancer. Marketing partner IsoRay Inc....
...Richland, Wash.) plans to launch GliaSite, a balloon catheter device delivering radioactive isotopes, next quarter. IsoRay...
...rights to GliaSite from Hologic. In June, Dr. Reddy's Laboratories Ltd. (NYSE:RDY, Hyderabad, India) granted IsoRay...
Items per page:
1 - 2 of 2
BioCentury | Dec 5, 2011
Company News

IsoRay sales and marketing update

...GliaSite radiation therapy system in the U.S. for use with Iotrex to treat brain cancer. IsoRay...
...for brain cancer from Dr. Reddy's Laboratories Ltd. (NYSE:RDY, Hyderabad, India) (see BioCentury, Sept. 19). IsoRay Inc....
BioCentury | Sep 19, 2011
Clinical News

GliaSite radiation therapy system regulatory update

...the GliaSite radiation therapy system for use with Iotrex to treat brain cancer. Marketing partner IsoRay Inc....
...Richland, Wash.) plans to launch GliaSite, a balloon catheter device delivering radioactive isotopes, next quarter. IsoRay...
...rights to GliaSite from Hologic. In June, Dr. Reddy's Laboratories Ltd. (NYSE:RDY, Hyderabad, India) granted IsoRay...
Items per page:
1 - 2 of 2